ELENA MANUELA
REIGADAS RAMÍREZ
Profesora asociada de Ciencias de la Salud
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Gregorio Marañón (55)
2024
-
Economic Burden of Clostridioides difficile Infection in European Countries
Advances in experimental medicine and biology, Vol. 1435, pp. 1-12
-
Impact of the Mediterranean Diet on the Gut Microbiome of a Well-Defined Cohort of Healthy Individuals
Nutrients, Vol. 16, Núm. 6
2023
-
A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic
BMC Microbiology, Vol. 23, Núm. 1
-
Amphotericin B, itraconazole, posaconazole, and isavuconazole MICs against clinical Mucorales isolates obtained by visual inspection and spectrophotometric reading according to the EUCAST 9.4 procedure
Medical mycology, Vol. 61, Núm. 5
-
Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates
Clinical Microbiology and Infection, Vol. 29, Núm. 12, pp. 1604.e1-1604.e6
-
Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Correction: Díaz-García et al. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis. J. Fungi 2022, 8, 1228
Journal of Fungi
-
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato
Mycoses, Vol. 66, Núm. 3, pp. 196-201
-
Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Non-Candida isolates from blood cultures and intra-abdominal samples: data derived from a multicentre prospective study conducted in Madrid
Revista Espanola de Quimioterapia
-
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
Open Forum Infectious Diseases, Vol. 10, Núm. 2
-
The Gastrointestinal Tract Is Pinpointed as a Reservoir of Candida albicans, Candida parapsilosis, and Candida tropicalis Genotypes Found in Blood and Intra-Abdominal Samples
Journal of Fungi, Vol. 9, Núm. 7
-
Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022
Antimicrobial Agents and Chemotherapy, Vol. 67, Núm. 11
2022
-
Blood and intra-abdominal Candida spp. from a multicentre study conducted in Madrid using EUCAST: emergence of fluconazole resistance in Candida parapsilosis, low echinocandin resistance and absence of Candida auris
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3102-3109
-
Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis
Journal of Fungi, Vol. 8, Núm. 11
-
Clostridioides difficile infection epidemiology and clinical characteristics in COVID-19 pandemic
Frontiers in Medicine, Vol. 9
-
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266
-
EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings
Antimicrobial agents and chemotherapy, Vol. 66, Núm. 9, pp. e0084922
-
Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 8
-
In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B
Clinical Microbiology and Infection, Vol. 28, Núm. 9, pp. 1291.e7-1291.e10